Sienna Biopharmaceuticals, Inc. (SNNAQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 157 Thousand | 120 Thousand |
| Gross Profit | - | - | - | - | -157 Thousand | -120 Thousand |
| Operating Expenses | - | - | - | - | 76.49 Million | 48.57 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 24.9 Million | 18.08 Million |
| Research and Development Expenses | - | - | - | - | 51.59 Million | 30.48 Million |
| Other Expenses | - | - | - | - | 3.02 Million | -2.26 Million |
| Cost and Expenses | - | - | - | - | 76.49 Million | 48.57 Million |
| Operating Income | - | - | - | - | -76.49 Million | -48.57 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | -157 Thousand | -290 Thousand |
| Earnings before Tax | - | - | - | - | -73.47 Million | -50.83 Million |
| Net Income | - | - | - | - | -73.31 Million | -50.54 Million |
| Earnings Per Share Basic | - | - | - | - | -3.59 | -5.19 |
| Earnings Per Share Diluted | - | - | - | - | -3.59 | -5.19 |
| Weighted Average Shares Outstanding | - | - | - | - | 20.45 Million | 9.73 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 20.45 Million | 9.73 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -76.34 Million | -48.45 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2019 Q3 | 2019 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | 8.84 Million | 7.72 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 5.02 Million | 2.64 Million |
| Research and Development Expenses | - | - | - | - | 3.82 Million | 5.08 Million |
| Other Expenses | - | - | - | - | -549 Thousand | -537 Thousand |
| Cost and Expenses | - | - | - | - | 8.84 Million | 7.72 Million |
| Operating Income | - | - | - | - | -6.03 Million | -7.72 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | -4.61 Million | - |
| Earnings before Tax | - | - | - | - | -8.58 Million | -8.26 Million |
| Net Income | - | - | - | - | -3.97 Million | -8.26 Million |
| Earnings Per Share Basic | - | - | - | - | -0.13 | -0.27 |
| Earnings Per Share Diluted | - | - | - | - | -0.13 | -0.27 |
| Weighted Average Shares Outstanding | - | - | - | - | 30.72 Million | 30.35 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 30.72 Million | 30.35 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -9.6 Million | -7.69 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
8987
9017
ALLT
0QOJ
TKYVY
0113